• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bullae for you: The increasing importance and implications of drug-induced bullous pemphigoid.

作者信息

Heymann Warren R

机构信息

Division of Dermatology, Cooper Medical School of Rowan University, Marlton, New Jersey.

出版信息

J Am Acad Dermatol. 2018 Dec;79(6):1026-1027. doi: 10.1016/j.jaad.2018.09.038. Epub 2018 Oct 1.

DOI:10.1016/j.jaad.2018.09.038
PMID:30287326
Abstract
摘要

相似文献

1
Bullae for you: The increasing importance and implications of drug-induced bullous pemphigoid.
J Am Acad Dermatol. 2018 Dec;79(6):1026-1027. doi: 10.1016/j.jaad.2018.09.038. Epub 2018 Oct 1.
2
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid.
J Am Acad Dermatol. 2019 Jun;80(6):e189-e190. doi: 10.1016/j.jaad.2019.01.086. Epub 2019 Feb 7.
3
Reply to: "Comment on 'Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid".回复：“对‘除二肽基肽酶-4抑制剂外的口服降糖药与大疱性类天疱疮无关：一项芬兰全国性病例对照研究’的评论以及一例胰高血糖素样肽-1受体激动剂诱发大疱性类天疱疮的病例报告”
J Am Acad Dermatol. 2019 Jun;80(6):e191-e192. doi: 10.1016/j.jaad.2019.02.005. Epub 2019 Feb 7.
4
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study".关于“除二肽基肽酶-4抑制剂外的口服降糖药与大疱性类天疱疮无关：一项芬兰全国性病例对照研究”的评论
J Am Acad Dermatol. 2018 Dec;79(6):e111-e112. doi: 10.1016/j.jaad.2018.06.043.
5
Reply to: "Comment on 'Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study'".回复：“对‘除二肽基肽酶-4抑制剂外的口服降糖药与大疱性类天疱疮无关：一项芬兰全国性病例对照研究’的评论”
J Am Acad Dermatol. 2018 Dec;79(6):e113-e114. doi: 10.1016/j.jaad.2018.06.042.
6
Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?大疱性类天疱疮与糖尿病：我们是否忽略了更宏观的情况？
J Am Acad Dermatol. 2018 Aug;79(2):e27. doi: 10.1016/j.jaad.2018.02.080.
7
Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology.伴有二肽基肽酶-4 抑制剂的大疱性类天疱疮：临床特征和发病机制。
J Diabetes Investig. 2019 Sep;10(5):1168-1170. doi: 10.1111/jdi.13060. Epub 2019 May 14.
8
Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.大疱性类天疱疮与二肽基肽酶-4 抑制剂：法国药物警戒数据库中的病例对照研究。
Br J Dermatol. 2016 Aug;175(2):296-301. doi: 10.1111/bjd.14601. Epub 2016 Jul 19.
9
Vildagliptin Significantly Increases the Risk of Bullous Pemphigoid: A Finnish Nationwide Registry Study.维格列汀显著增加大疱性类天疱疮风险：一项芬兰全国性登记研究
J Invest Dermatol. 2018 Jul;138(7):1659-1661. doi: 10.1016/j.jid.2018.01.027. Epub 2018 Feb 7.
10
Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis.二肽基肽酶-4 抑制剂相关性大疱性类天疱疮患者合并获得性反应性穿孔性胶原病。
J Dermatol. 2018 May;45(5):600-602. doi: 10.1111/1346-8138.14254. Epub 2018 Feb 14.

引用本文的文献

1
Atypical Bullous Pemphigoid After Linagliptin Intake.利拉利汀用药后出现非典型大疱性类天疱疮。
Am J Case Rep. 2021 Sep 29;22:e932356. doi: 10.12659/AJCR.932356.
2
The pathogenesis of bullous skin diseases.大疱性皮肤病的发病机制。
J Transl Autoimmun. 2019 Aug 26;2:100014. doi: 10.1016/j.jtauto.2019.100014. eCollection 2019 Dec.